Naheed Bano
Holy Family Hospital
14 Papers
22 Citations
Naheed Bano is an academic researcher from Holy Family Hospital. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Explorations of CRISPR/Cas9 for improving the long-term efficacy of universal CAR-T cells in cancer immunotherapy.
Muhammad Naeem,Abu Hazafa,Naheed Bano,Rashid Ali,M. Farooq,Saiful Izwan Abd Razak,Tze Yan Lee,Sutha Devaraj +7 more
TL;DR: In this article , the authors explored the innovative aspects of CRISPR/Cas9 technology for developing next-generation/universal allogeneic CAR-T cells and pointed out the off-target effects associated with CRISpl/Cas 9 genome editing.
18
A study of maternal mortality in 8 principal hospitals in Pakistan in 2009.
TL;DR: To determine maternal mortality to assess the achievement of Millennium Development Goal 5 in Pakistan and suggest remedial measures, a database of maternal mortality in Pakistan is analyzed.
16
•Journal Article
Case based learning and traditional teaching strategies: where lies the future
TL;DR: Although test performance was similar in both the groups, students expressed strong preference for CBL as compared to traditional methods.
10
Assessment of insects diversity with the influence of industrial pollutants in agricultural zones of District Sialkot, Pakistan
Ayesha Asghar,Omema Qadeer,Sajid Mushtaq,Sadia Maalik,Waqar Majeed,Naheed Bano,Shahla Nargis +6 more
- 18 Apr 2022
TL;DR: In this article , Asghar A, Qadeer O, Mushtaq S, Maalik S, Majeed W, Bano N, Nargis S. Assessment of insects diversity with the influence of industrial pollutants in agricultural zones of District Sialkot, Pakistan.
Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients
Muhammad Naeem,Naheed Bano,Saba Manzoor,Aftab Ahmad,Nayla Munawar,Saiful Izwan Abd Razak,Tze Yan Lee,Sutha Devaraj,Abu Hazafa +8 more
TL;DR: In this paper , the authors highlighted the attack of SARS-CoV-2 on liver hepatocytes by exploring the cellular and molecular events underlying the pathophysiological mechanisms in COVID-19 patients with liver injury.